ARGS - Argos Therapeutics, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201712/31/201612/31/201512/31/2014
Total Revenue1,899.398945.468518.3291,974.019
Cost of Revenue----
Gross Profit1,899.398945.468518.3291,974.019
Operating Expenses
Research Development21,656.09637,107.23662,054.82345,358.36
Selling General and Administrative12,183.23514,203.30111,011.0118,599.359
Non Recurring----
Others----
Total Operating Expenses33,839.33151,310.53773,065.83453,957.719
Operating Income or Loss-31,939.933-50,365.069-72,547.505-51,983.7
Income from Continuing Operations
Total Other Income/Expenses Net-8,637.577-2,663.041-2,241.016-1,322.238
Earnings Before Interest and Taxes-31,939.933-50,365.069-72,547.505-51,983.7
Interest Expense-1,308.201-1,774.74-2,263.599-1,123.579
Income Before Tax-40,577.51-53,028.11-74,788.521-53,305.938
Income Tax Expense----
Minority Interest----
Net Income From Continuing Ops-40,577.51-53,028.11-74,788.521-53,305.938
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-40,577.51-53,028.11-74,788.521-53,305.938
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-40,577.51-53,028.11-74,788.521-54,169.164